These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 23928214)
21. Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression. Huang HY; Kuo WT; Chou MJ; Huang YY J Biomed Mater Res A; 2011 Jun; 97(3):330-8. PubMed ID: 21465641 [TBL] [Abstract][Full Text] [Related]
22. Sialic Acid-Targeted Nanovectors with Phenylboronic Acid-Grafted Polyethylenimine Robustly Enhance siRNA-Based Cancer Therapy. Ji M; Li P; Sheng N; Liu L; Pan H; Wang C; Cai L; Ma Y ACS Appl Mater Interfaces; 2016 Apr; 8(15):9565-76. PubMed ID: 27007621 [TBL] [Abstract][Full Text] [Related]
23. Combined Hydrophobization of Polyethylenimine with Cholesterol and Perfluorobutyrate Improves siRNA Delivery. Wu P; Luo X; Wu H; Zhang Q; Wang K; Sun M; Oupicky D Bioconjug Chem; 2020 Mar; 31(3):698-707. PubMed ID: 31967460 [TBL] [Abstract][Full Text] [Related]
24. Controlled cytoplasmic and nuclear localization of plasmid DNA and siRNA by differentially tailored polyethylenimine. Shim MS; Kwon YJ J Control Release; 2009 Feb; 133(3):206-13. PubMed ID: 18992289 [TBL] [Abstract][Full Text] [Related]
25. Dependence of transgene expression and the relative buffering capacity of dextran-grafted polyethylenimine. Tseng WC; Fang TY; Su LY; Tang CH Mol Pharm; 2005; 2(3):224-32. PubMed ID: 15934783 [TBL] [Abstract][Full Text] [Related]
26. Microfluidic-Based Holonomic Constraints of siRNA in the Kernel of Lipid/Polymer Hybrid Nanoassemblies for Improving Stable and Safe In Vivo Delivery. Wei W; Sun J; Guo XY; Chen X; Wang R; Qiu C; Zhang HT; Pang WH; Wang JC; Zhang Q ACS Appl Mater Interfaces; 2020 Apr; 12(13):14839-14854. PubMed ID: 32182035 [TBL] [Abstract][Full Text] [Related]
27. In Vivo Antitumor Activity of Folate-Conjugated Cholic Acid-Polyethylenimine Micelles for the Codelivery of Doxorubicin and siRNA to Colorectal Adenocarcinomas. Amjad MW; Amin MC; Katas H; Butt AM; Kesharwani P; Iyer AK Mol Pharm; 2015 Dec; 12(12):4247-58. PubMed ID: 26567518 [TBL] [Abstract][Full Text] [Related]
28. siRNA therapy in cutaneous T-cell lymphoma cells using polymeric carriers. Sahin B; Fife J; Parmar MB; Valencia-Serna J; Gul-Uludağ H; Jiang X; Weinfeld M; Lavasanifar A; Uludağ H Biomaterials; 2014 Nov; 35(34):9382-94. PubMed ID: 25128374 [TBL] [Abstract][Full Text] [Related]
29. P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells. Navarro G; Sawant RR; Biswas S; Essex S; Tros de Ilarduya C; Torchilin VP Nanomedicine (Lond); 2012 Jan; 7(1):65-78. PubMed ID: 22191778 [TBL] [Abstract][Full Text] [Related]
30. A unique and highly efficient non-viral DNA/siRNA delivery system based on PEI-bisepoxide nanoparticles. Swami A; Kurupati RK; Pathak A; Singh Y; Kumar P; Gupta KC Biochem Biophys Res Commun; 2007 Nov; 362(4):835-41. PubMed ID: 17822674 [TBL] [Abstract][Full Text] [Related]
32. Acute in vivo toxicity mitigation of PEI-coated maghemite nanoparticles using controlled oxidation and surface modifications toward siRNA delivery. Israel LL; Lellouche E; Ostrovsky S; Yarmiayev V; Bechor M; Michaeli S; Lellouche JP ACS Appl Mater Interfaces; 2015 Jul; 7(28):15240-55. PubMed ID: 26120905 [TBL] [Abstract][Full Text] [Related]
33. Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multidrug-resistant tumors. Essex S; Navarro G; Sabhachandani P; Chordia A; Trivedi M; Movassaghian S; Torchilin VP Gene Ther; 2015 Mar; 22(3):257-266. PubMed ID: 25354685 [TBL] [Abstract][Full Text] [Related]
34. A molecular dynamics simulation study on the effect of lipid substitution on polyethylenimine mediated siRNA complexation. Sun C; Tang T; Uludag H Biomaterials; 2013 Apr; 34(11):2822-33. PubMed ID: 23352043 [TBL] [Abstract][Full Text] [Related]
35. Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Grayson AC; Doody AM; Putnam D Pharm Res; 2006 Aug; 23(8):1868-76. PubMed ID: 16845585 [TBL] [Abstract][Full Text] [Related]
36. Efficient siRNA delivery and gene silencing using a lipopolypeptide hybrid vector mediated by a caveolae-mediated and temperature-dependent endocytic pathway. Kasai H; Inoue K; Imamura K; Yuvienco C; Montclare JK; Yamano S J Nanobiotechnology; 2019 Jan; 17(1):11. PubMed ID: 30670041 [TBL] [Abstract][Full Text] [Related]
37. Self-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene delivery. Ko YT; Kale A; Hartner WC; Papahadjopoulos-Sternberg B; Torchilin VP J Control Release; 2009 Jan; 133(2):132-8. PubMed ID: 18929605 [TBL] [Abstract][Full Text] [Related]
38. Investigation of siRNA-loaded polyethylenimine-coated human serum albumin nanoparticle complexes for the treatment of breast cancer. Abbasi S; Paul A; Prakash S Cell Biochem Biophys; 2011 Nov; 61(2):277-87. PubMed ID: 21556941 [TBL] [Abstract][Full Text] [Related]
39. Biscarbamate cross-linked low molecular weight Polyethylenimine polycation as an efficient intra-cellular delivery cargo for cancer therapy. Ge X; Feng J; Chen S; Zhang C; Ouyang Y; Liu Z; Yuan W J Nanobiotechnology; 2014 Apr; 12():13. PubMed ID: 24708586 [TBL] [Abstract][Full Text] [Related]
40. The PEI-introduced CS shell/PMMA core nanoparticle for silencing the expression of E6/E7 oncogenes in human cervical cells. Saengkrit N; Sanitrum P; Woramongkolchai N; Saesoo S; Pimpha N; Chaleawlert-Umpon S; Tencomnao T; Puttipipatkhachorn S Carbohydr Polym; 2012 Oct; 90(3):1323-9. PubMed ID: 22939347 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]